콘텐츠로 건너뛰기
Merck
  • Staphylococcal infections in children, California, USA, 1985-2009.

Staphylococcal infections in children, California, USA, 1985-2009.

Emerging infectious diseases (2012-12-25)
Kathleen Gutierrez, Meira S Halpern, Clea Sarnquist, Shila Soni, Anna Chen Arroyo, Yvonne Maldonado
초록

We conducted a retrospective, observational, population-based study to investigate the effect of staphylococcal infections on the hospitalization of children in California during 1985-2009. Hospitalized children with staphylococcal infections were identified through the California Office of Statewide Health Planning and Development discharge database. Infections were categorized as community onset, community onset health care-associated, or hospital onset. Infection incidence was calculated relative to all children and to those hospitalized in acute-care facilities. A total of 140,265 records were analyzed. Overall incidence increased from 49/100,000 population in 1985 to a peak of 83/100,000 in 2006 and dropped to 73/100,000 in 2009. Staphylococcal infections were associated with longer hospital stays and higher risk for death relative to all-cause hospitalizations of children. The number of methicillin-resistant Staphylococcus aureus infections increased, and the number of methicillin-susceptible S. aureus infections remained unchanged. Children <3 years of age, Blacks, and those without private insurance were at higher risk for hospitalization.

MATERIALS
제품 번호
브랜드
제품 설명

Millipore
MRSA Selective Supplement, suitable for microbiology
Sigma-Aldrich
Methicillin sodium salt, ≥95% (HPLC)